We are live on
!
Find out more
AHC
Anderson Hoagland & Co Portfolio holdings
AUM
$1.28B
1-Year Est. Return
29.05%
This Fund
S&P 500
This Quarter
Est. Return
+11.42%
1 Year Est. Return
+29.05%
3 Year Est. Return
+95.06%
5 Year Est. Return
+101.06%
10 Year Est. Return
+495.38%
AUM
$177M
AUM Growth
+$12.1M
(+7.3%)
Cap. Flow
-$2.91M
Cap. Flow
% of AUM
-1.65%
Top 10 Holdings %
Top 10 Hldgs %
44.53%
Holding
89
New
5
Increased
15
Reduced
16
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.82M |
| 2 |
Sumitomo Mitsui Financial
SMFG
|
+$877K |
| 3 |
Intel
INTC
|
+$825K |
| 4 |
Corpay
CPAY
|
+$765K |
| 5 |
Snap-on
SNA
|
+$754K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.8M |
| 2 |
Illumina
ILMN
|
+$1.17M |
| 3 |
Diageo
DEO
|
+$1.07M |
| 4 |
Bank of America
BAC
|
+$973K |
| 5 |
Hubbell
HUBB
|
+$785K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.55% |
| 2 | Financials | 20.79% |
| 3 | Consumer Discretionary | 12.69% |
| 4 | Communication Services | 10.48% |
| 5 | Industrials | 9.96% |
Similar funds
SA
FBCM
CAM
EIA
TC
CTA
MA
COCM
Anderson Hoagland & Co's Q4 2019 Portfolio in Review
As of Q4 2019, Anderson Hoagland & Co held 89 positions worth $177M, up 7.3% from $165M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Anderson Hoagland & Co's Q4 2019 filing shows 5 new, 15 increased, 16 reduced and 5 closed positions. Its largest new stake was Bristol-Myers Squibb: 31,695 shares worth $1.8M. The largest sale was Celgene Corp, an estimated $1.8M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Anderson Hoagland & Co's largest Q4 2019 buy was Bristol-Myers Squibb: 31,695 shares worth $1.8M.
- Anderson Hoagland & Co added most to Intel in Q4 2019, an estimated $825K increase.
- Anderson Hoagland & Co's biggest Q4 2019 reduction was Illumina, cutting an estimated $1.17M.
- Anderson Hoagland & Co fully exited Celgene Corp in Q4 2019, selling an estimated $1.8M.
- Anderson Hoagland & Co's ten largest holdings make up 45% of its $177M portfolio in Q4 2019.
- Anderson Hoagland & Co opened 5 new positions and closed 5 in Q4 2019.
- Anderson Hoagland & Co's portfolio value rose 7.3% quarter-over-quarter to $177M.
Based on Anderson Hoagland & Co's 13F filing for Q4 2019, filed 6 Jan 2020.